- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07768995
The Effect of a Psychiatric Nursing Approach Based on the Tidal Model on Psychological Resilience and Self-Compassion Levels in Patients Diagnosed With Anxiety Disorder
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This study aims to evaluate the effectiveness of a Tidal Model-based psychiatric nursing intervention in clinical practice and to emphasize the importance of holistic, patient-centered approaches in nursing care for patients with anxiety disorders.
Study Hypotheses:
Hypothesis 1 (H1): The psychological resilience levels of individuals who receive the Tidal Model-based psychiatric nursing approach are statistically significantly higher after the intervention compared to the individuals in the control group.
Hypothesis 2 (H2): The self-compassion levels of individuals who receive the Tidal Model-based psychiatric nursing approach are statistically significantly higher after the intervention compared to the individuals in the control group.
Hypothesis 3 (H3): The psychological resilience levels of individuals in the intervention group show a statistically significant increase after the intervention compared to before the intervention.
Hypothesis 4 (H4): The self-compassion levels of individuals in the intervention group show a statistically significant increase after the intervention compared to before the intervention.
Null Hypothesis (H0): There is no statistically significant difference between the intervention and control groups in terms of psychological resilience and self-compassion levels after the intervention.
Anxiety Disorder, Online Care, Tidal Model, Self-Compassion, Psychological Resilience, Psychiatric Nursing
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Ankara
-
Ankara, Ankara, Turquía (Türkiye), 06010
- University of Health Sciences, Gulhane Institute of Health Sciences
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Being officially diagnosed with Anxiety Disorder according to DSM-5 diagnostic criteria,
- Being between 18-65 years of age,
- Having access to a smartphone, computer, and internet connection sufficient to participate in online sessions,
- Volunteering to participate in the study and signing the Informed Consent Form.
Exclusion Criteria:
- Having acute psychosis, bipolar disorder, dementia, or a severe neurological disease in addition to anxiety disorder,
- Having cognitive or sensory loss that prevents communication, vision, or hearing,
- Currently participating in another active psychotherapy or psychosocial intervention program simultaneously.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention Group
Participants in this group receive one-on-one online psychiatric nursing interventions based on the Tidal Model, conducted via remote video conferencing.
The sessions aim to enable patients to recognize their inner strengths and to increase their psychological resilience and self-compassion levels.
|
One-on-one nursing sessions were conducted via online video conferencing platforms based on the philosophy of the Tidal Model.
The intervention involves session processes aligned with the model's domains (Self, World, Partnership) and its ten commitments, enabling patients to construct their own stories, develop anxiety coping skills (psychological resilience), and cultivate a supportive inner voice (self-compassion).
|
|
Sin intervención: Control Group
Participants in this group did not receive any additional psychosocial or nursing interventions between the dates of completing the pre-test and post-test forms.
They completed the process continuing only with their routine clinical psychiatric follow-ups and medical treatments at the healthcare institution where they were registered.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Psychological Resilience Scale Score
Periodo de tiempo: Baseline (Week 0, pre-test 1 day before intervention) and Post-test (Week 8, 1 day after completion of the 8-week intervention)
|
Change in psychological resilience levels as measured by the Resilience Scale for Adults (33 items, 5-point Likert scale).
Minimum score is 33 and maximum score is 165.
Higher scores indicate higher levels of psychological resilience (better outcome).
Pre-test was administered at Week 0 before intervention, and post-test was administered at Week 8 immediately following the 8-week intervention.
|
Baseline (Week 0, pre-test 1 day before intervention) and Post-test (Week 8, 1 day after completion of the 8-week intervention)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Self-Compassion Scale Score
Periodo de tiempo: Baseline (Week 0, pre-test 1 day before intervention) and Post-test (Week 8, 1 day after completion of the 8-week intervention)
|
Change in self-compassion levels as measured by the Turkish version of the Self-Compassion Scale (Deniz, Kesici, & Sumer, 2008; 24 items, 5-point Likert scale).
Minimum score is 24 and maximum score is 120.
Higher scores indicate higher levels of self-compassion (better outcome).
Pre-test was administered at Week 0 before intervention, and post-test was administered at Week 8 immediately following the 8-week intervention.
|
Baseline (Week 0, pre-test 1 day before intervention) and Post-test (Week 8, 1 day after completion of the 8-week intervention)
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2025-462
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .